FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076131977> ?p ?o ?g. }

• W2076131977 endingPage "1716" @default.
• W2076131977 startingPage "1703" @default.
• W2076131977 abstract "Coltuximab ravtansine (SAR3419) is an antibody–drug conjugate (ADC) targeting CD19 created by conjugating a derivative of the potent microtubule-acting cytotoxic agent, maytansine, to a version of the anti-CD19 antibody, anti-B4, that was humanized as an IgG1 by variable domain resurfacing. Four different linker-maytansinoid constructs were synthesized (average ∼3.5 maytansinoids/antibody for each) to evaluate the impact of linker-payload design on the activity of the maytansinoid-ADCs targeting CD19. The ADC composed of DM4 (N2′-deacetyl-N2′-[4-mercapto-4-methyl-1-oxopentyl]maytansine) conjugated to antibody via the N-succinimidyl-4-(2-pyridyldithio)butyrate (SPDB) linker was selected for development as SAR3419. A molar ratio for DM4/antibody of between 3 and 5 was selected for the final design of SAR3419. Evaluation of SAR3419 in Ramos tumor xenograft models showed that the minimal effective single dose was about 50 μg/kg conjugated DM4 (∼2.5 mg/kg conjugated antibody), while twice this dose gave complete regressions in 100% of the mice. SAR3419 arrests cells in the G2/M phase of the cell cycle, ultimately leading to apoptosis after about 24 h. The results of in vitro and in vivo studies with SAR3419 made with DM4 that was [3H]-labeled at the C20 methoxy group of the maytansinoid suggest a mechanism of internalization and intracellular trafficking of SAR3419, ultimately to lysosomes, in which the antibody is fully degraded, releasing lysine-Nε-SPDB-DM4 as the initial metabolite. Subsequent intracellular reduction of the disulfide bond between linker and DM4 generates the free thiol species, which is then converted to S-methyl DM4 by cellular methyl transferase activity. We provide evidence to suggest that generation of S-methyl DM4 in tumor cells may contribute to in vivo tumor eradication via bystander killing of neighboring tumor cells. Furthermore, we show that S-methyl DM4 is converted to the sulfoxide and sulfone derivatives in the liver, suggesting that hepatic catabolism of the payload to less cytotoxic maytansinoid species contributes to the overall therapeutic window of SAR3419. This compound is currently in phase II clinical evaluation for the treatment of diffuse large B cell lymphoma." @default.
• W2076131977 created "2016-06-24" @default.
• W2076131977 creator A5002328389 @default.
• W2076131977 creator A5036231578 @default.
• W2076131977 creator A5036537233 @default.
• W2076131977 creator A5056571490 @default.
• W2076131977 creator A5059443646 @default.
• W2076131977 creator A5062197147 @default.
• W2076131977 creator A5079652346 @default.
• W2076131977 creator A5087222033 @default.
• W2076131977 date "2015-04-27" @default.
• W2076131977 modified "2023-10-03" @default.
• W2076131977 title "Design of Coltuximab Ravtansine, a CD19-Targeting Antibody–Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure–Activity Relationships and Preclinical Evaluation" @default.
• W2076131977 cites W1548735291 @default.
• W2076131977 cites W1607133602 @default.
• W2076131977 cites W1795111525 @default.
• W2076131977 cites W1915689252 @default.
• W2076131977 cites W1968166269 @default.
• W2076131977 cites W1971738718 @default.
• W2076131977 cites W1984007340 @default.
• W2076131977 cites W1995431674 @default.
• W2076131977 cites W2000568282 @default.
• W2076131977 cites W2004783782 @default.
• W2076131977 cites W2037036587 @default.
• W2076131977 cites W2041142448 @default.
• W2076131977 cites W2043103956 @default.
• W2076131977 cites W2053887681 @default.
• W2076131977 cites W2057463153 @default.
• W2076131977 cites W2065528643 @default.
• W2076131977 cites W2097529056 @default.
• W2076131977 cites W2101893838 @default.
• W2076131977 cites W2104187048 @default.
• W2076131977 cites W2109440389 @default.
• W2076131977 cites W2126181165 @default.
• W2076131977 cites W2130011407 @default.
• W2076131977 cites W2131770134 @default.
• W2076131977 cites W2132872213 @default.
• W2076131977 cites W2132895530 @default.
• W2076131977 cites W2138608284 @default.
• W2076131977 cites W2139761471 @default.
• W2076131977 cites W2148846557 @default.
• W2076131977 cites W2159537998 @default.
• W2076131977 cites W2159967578 @default.
• W2076131977 cites W2163451755 @default.
• W2076131977 cites W2164337721 @default.
• W2076131977 cites W2165800290 @default.
• W2076131977 cites W2166288283 @default.
• W2076131977 cites W2168926834 @default.
• W2076131977 cites W2169000897 @default.
• W2076131977 cites W2267215445 @default.
• W2076131977 cites W2324366850 @default.
• W2076131977 cites W85464595 @default.
• W2076131977 doi "https://doi.org/10.1021/acs.molpharmaceut.5b00175" @default.
• W2076131977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25856201" @default.
• W2076131977 hasPublicationYear "2015" @default.
• W2076131977 type Work @default.
• W2076131977 sameAs 2076131977 @default.
• W2076131977 citedByCount "41" @default.
• W2076131977 countsByYear W20761319772015 @default.
• W2076131977 countsByYear W20761319772016 @default.
• W2076131977 countsByYear W20761319772017 @default.
• W2076131977 countsByYear W20761319772018 @default.
• W2076131977 countsByYear W20761319772019 @default.
• W2076131977 countsByYear W20761319772020 @default.
• W2076131977 countsByYear W20761319772021 @default.
• W2076131977 countsByYear W20761319772022 @default.
• W2076131977 countsByYear W20761319772023 @default.
• W2076131977 crossrefType "journal-article" @default.
• W2076131977 hasAuthorship W2076131977A5002328389 @default.
• W2076131977 hasAuthorship W2076131977A5036231578 @default.
• W2076131977 hasAuthorship W2076131977A5036537233 @default.
• W2076131977 hasAuthorship W2076131977A5056571490 @default.
• W2076131977 hasAuthorship W2076131977A5059443646 @default.
• W2076131977 hasAuthorship W2076131977A5062197147 @default.
• W2076131977 hasAuthorship W2076131977A5079652346 @default.
• W2076131977 hasAuthorship W2076131977A5087222033 @default.
• W2076131977 hasConcept C111919701 @default.
• W2076131977 hasConcept C134306372 @default.
• W2076131977 hasConcept C1491633281 @default.
• W2076131977 hasConcept C150903083 @default.
• W2076131977 hasConcept C159654299 @default.
• W2076131977 hasConcept C185592680 @default.
• W2076131977 hasConcept C197336794 @default.
• W2076131977 hasConcept C203014093 @default.
• W2076131977 hasConcept C207001950 @default.
• W2076131977 hasConcept C2777325958 @default.
• W2076131977 hasConcept C2778556491 @default.
• W2076131977 hasConcept C2778957590 @default.
• W2076131977 hasConcept C2780557392 @default.
• W2076131977 hasConcept C33923547 @default.
• W2076131977 hasConcept C41008148 @default.
• W2076131977 hasConcept C502942594 @default.
• W2076131977 hasConcept C542903549 @default.
• W2076131977 hasConcept C55493867 @default.
• W2076131977 hasConcept C71924100 @default.
• W2076131977 hasConcept C79879829 @default.
• W2076131977 hasConcept C86803240 @default.
• W2076131977 hasConcept C98274493 @default.

• next